Bigul

Vakrangee Limited-$ - 511431 - Corrigendum To The Notice Of Postal Ballot Dated February 08, 2024.

Corrigendum to the Notice of Postal Ballot dated February 08, 2024.
23-02-2024
Bigul

Vakrangee Limited-$ - 511431 - Grant Of Options Under ESOP Scheme 2014 Of The Company.

Grant of Options under ESOP Scheme 2014 of the Company.
22-02-2024
Bigul

Vakrangee Limited-$ - 511431 - Announcement under Regulation 30 (LODR)-Change in Directorate

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Resignation of LIC Nominee Director as his term has been completed and proposal for Nominated new LIC Nominee Director.
13-02-2024
Bigul

Vakrangee Limited-$ - 511431 - VAKRANGEE LIMITED Q3 FY2023-24 RESULTS UPDATE PRESENTATION.

VAKRANGEE LIMITED Q3 FY2023-24 RESULTS UPDATE PRESENTATION.
06-02-2024
Bigul

Vakrangee Limited-$ - 511431 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

REVENUE INCREASES BY 6.16%, PAT INCREASES BY 871.85% ON YOY BASIS, TO FORAY INTO SOURCING AND DISTRIBUTION OF PRIVATE LABEL AND WHITE LABEL PRODUCTS.
06-02-2024
Bigul

Vakrangee Limited-$ - 511431 - Announcement under Regulation 30 (LODR)-Preferential Issue

Outcome of the Board Meeting Held on February 6, 2024 for Preferential Allotment of Convertible warrants.
06-02-2024
Bigul

Vakrangee Limited-$ - 511431 - Board Meeting Outcome for Un-Audited (Standalone & Consolidated) Financial Results For The Third Quarter And Nine Months Ended December 31, 2023.

Un-audited (Standalone & Consolidated) Financial Results for the third Quarter and nine months ended December 31, 2023.
06-02-2024
Bigul

Vakrangee Limited-$ - 511431 - Board Meeting Intimation for Inter Alia, To Transact The Following Businesses. 1. To Consider And Approve Un-Audited (Standalone & Consolidated) Financial Results For The Quarter And Nine Months Ended December 31, 2023. 2. To Consider The Proposal For Raising Of Funds.

Vakrangee Limited-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 ,inter alia, to consider and approve 1. Un-audited (Standalone & Consolidated) Financial Results for the quarter and nine months ended December 31, 2023. 2. To consider the proposal for raising of funds by way of a rights issue, warrant, preferential issue including a qualified institutions placement or through any other permissible mode and/or combination thereof as may be considered appropriate, by way of issue of equity shares or any other eligible securities, subject to all such regulatory/ statutory approvals as may be required including the approval of shareholders of the Company.
29-01-2024
Next Page
Close

Let's Open Free Demat Account